TIDMSN.
RNS Number : 7085R
Smith & Nephew Plc
09 March 2021
SMITH & NEPHEW PLC
9 March 2021
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE
REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND
PERSONS CLOSELY ASSOCIATED WITH THEM.
1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2010 AND 2020
On 7 March 2021, the following awards of US$0.20 ordinary shares
(the "Shares") in Smith & Nephew plc (the "Company") vested
under the Smith & Nephew Global Share Plan 2010.
i. VESTING ON 7 MARCH 2021 OF 2018 PERFORMANCE SHARE PROGRAMME
AWARDS MADE UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN
2010:
The awards were granted under the Global Share Plan 2010 on 7
March 2018 and as announced on 3 February 2021, vested at 47% of
target and settled on 8 March 2021 being the first business date
after the third anniversary of the awards. A number of Shares were
sold to cover taxation obligations arising on the vesting of the
awards. The number of Shares acquired includes the dividend
equivalent Shares which participants receive on vested Shares.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
-------------------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
-------------------------------------------------------
LEI 213800ZTMDN8S67S1H61
-------------------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
Description of the Smith & Nephew plc ordinary shares of USD
financial instrument, 0.20 each
type of instrument
-------------------------------------------------------
Identification code ISIN: GB0009223206
-------------------------------------------------------
Nature of the transaction Vesting of Smith & Nephew Global Share
Plan 2010 Performance Share Programme awards
granted on 7 March 2018.
-------------------------------------------------------
Date of Transaction 2021 - 03 - 08
-------------------------------------------------------
Place of Transaction London Stock Exchange (XLON)
------------------------------------------------------- -----------------
Total Ordinary
Share Holding
Total Ordinary as a % of
Share Holding the Company's
following ISC following
Name Price Aggregated the transaction the transaction
(Position) Status (GBP) Volume information * *
---------- -------- ----------- ------------- ----------------- -----------------
8,123
(of which 69762.76313
Bradley Cannon 3,616 ordinary shares
(President were sold (including
Sports Medicine and 4,507 N/A Single 2,101.64550
& ENT) PDMR 13.4385 retained) Transaction in ADS') 0.00788%
---------- -------- ----------- ------------- ----------------- -----------------
3,869
Phil Cowdy (of which
(Chief Business 1,825
Development were sold
& Corporate and 2,044 N/A Single 37,044.19975
Affairs Officer) PDMR 13.4385 retained) Transaction ordinary shares 0.00419%
---------- -------- ----------- ------------- ----------------- -----------------
6,185
(of which 93,097.00000
2,443 ordinary shares
Elga Lohler were sold (including
(Chief HR and 3,742 N/A Single 3,105.00000
Officer) PDMR 13.4385 retained) Transaction in ADS') 0.01052%
---------- -------- ----------- ------------- ----------------- -----------------
6,129
Catheryn (of which 66,886.23565
O'Rourke 2,089 ordinary shares
(Chief Legal were sold (including
& Compliance and 4,040 N/A Single 5,818.25734
Officer) PDMR 13.4385 retained) Transaction in ADS') 0.00756%
---------- -------- ----------- ------------- ----------------- -----------------
6,966
(of which
Vasant Padmanabhan 2,365
(President were sold
Research and 4,601 N/A Single 49,890.00000
& Development) PDMR 13.4385 retained) Transaction ordinary shares 0.00564%
---------- -------- ----------- ------------- ----------------- -----------------
2,727
(of which
1,287
Susan Swabey were sold
(Company and 1,440 N/A Single 45,759.83952
Secretary) PDMR 13.4385 retained) Transaction ordinary shares 0.00517%
---------- -------- ----------- ------------- ----------------- -----------------
* including those held by Persons Closely Associated with the
Director/PDMR. All figures in these columns are stated to 5 decimal
places where applicable.
ii. FINAL VESTING ON 7 MARCH 2021 OF 2018 EQUITY INCENTIVE
PROGRAMME AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:
The awards were granted under the Global Share Plan 2010 on 7
March 2018. One third of the Shares vested on 7 March 2019, a
further third vested on 7 March 2020 and the final third vested on
7 March 2021. A number of Shares were sold to cover taxation
obligations arising on the vesting of the awards. The number of
Shares acquired includes the dividend equivalent Shares which
participants receive on vested Shares.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
--------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
--------------------------------------------
LEI 213800ZTMDN8S67S1H61
--------------------------------------------
Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
Description of the Smith & Nephew plc ordinary shares of
financial instrument, USD 0.20 each
type of instrument
--------------------------------------------
Identification code ISIN: GB0009223206
--------------------------------------------
Nature of the transaction Final vesting of Equity Incentive Programme
awards granted on 7 March 2018 under
the Smith & Nephew Global Share Plan
2010.
--------------------------------------------
Date of Transaction 2021 - 03 - 08
--------------------------------------------
Place of Transaction London Stock Exchange (XLON)
--------------------------------------------
Total Ordinary
Share Holding
Total Ordinary as a % of
Share Holding the Company's
following ISC following
Name Price Aggregated the transaction the transaction
(Position) Status (GBP) Volume information * *
5,240
(of which 72,669.76313
Bradley Cannon 2,333 ordinary
(President were sold shares (including
Sports Medicine and 2,907 N/A Single 2,101.64550
& ENT) PDMR 13.4385 retained) Transaction in ADS') 0.00821%
---------- -------- ----------- ------------- ------------------- -----------------
3,089
Phil Cowdy (of which
(Chief Business 1,457
Development were sold 38,676.19975
& Corporate and 1,632 N/A Single ordinary
Affairs Officer) PDMR 13.4385 retained) Transaction shares 0.00437%
---------- -------- ----------- ------------- ------------------- -----------------
4,389
(of which 95,752.00000
1,734 ordinary
Elga Lohler were sold shares (including
(Chief HR and 2,655 N/A Single 3,105.00000
Officer) PDMR 13.4385 retained) Transaction in ADS') 0.01082%
---------- -------- ----------- ------------- ------------------- -----------------
4,350
Catheryn (of which 69,753.23565
O'Rourke 1,483 ordinary
(Chief Legal were sold shares (including
& Compliance and 2,867 N/A Single 5,818.25734
Officer) PDMR 13.4385 retained) Transaction in ADS') 0.00788%
---------- -------- ----------- ------------- ------------------- -----------------
4,494
(of which
Vasant Padmanabhan 1,526
(President were sold 52,858.00000
Research and 2,968 N/A Single ordinary
& Development) PDMR 13.4385 retained) Transaction shares 0.00597%
---------- -------- ----------- ------------- ------------------- -----------------
1,936
(of which
914 were
Susan Swabey sold and 46,781.83952
(Company 1,022 N/A Single ordinary
Secretary) PDMR 13.4385 retained) Transaction shares 0.00529%
---------- -------- ----------- ------------- ------------------- -----------------
* including those held by Persons Closely Associated with the
Director/PDMR. All figures in these columns are stated to 5 decimal
places where applicable.
iii. PARTIAL VESTING ON 7 MARCH 2021 OF 2019 EQUITY INCENTIVE
PROGRAMME AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:
The awards were granted under the Global Share Plan 2010 on 7
March 2019. One third of the Shares vested on 7 March 2020, a
further third vested on 7 March 2021 and the final third will vest
on 7 March 2022. A number of Shares were sold to cover taxation
obligations arising on the vesting of the awards. The number of
Shares acquired includes the dividend equivalent Shares which
participants receive on vested Shares.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
----------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
----------------------------------------------
LEI 213800ZTMDN8S67S1H61
----------------------------------------------
Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
Description of the Smith & Nephew plc ordinary shares of
financial instrument, USD 0.20 each
type of instrument
----------------------------------------------
Identification code ISIN: GB0009223206
----------------------------------------------
Nature of the transaction Partial vesting of Equity Incentive Programme
awards granted on 7 March 2019 under
the Smith & Nephew Global Share Plan
2010 .
----------------------------------------------
Date of Transaction 2021 - 03 - 08
----------------------------------------------
Place of Transaction London Stock Exchange (XLON)
----------------------------------------------
Total Ordinary
Share Holding
Total Ordinary as a % of
Share Holding the Company's
following ISC following
Name Price Aggregated the transaction the transaction
(Position) Status (GBP) Volume information * *
4,859
(of which 75,366.76313
Bradley Cannon 2,162 ordinary
(President were sold shares (including
Sports Medicine and 2,697 N/A Single 2,101.64550
& ENT) PDMR 13.4385 retained) Transaction in ADS') 0.00852%
---------- -------- --------------- ------------- ------------------- -----------------
2,423
Phil Cowdy (of which
(Chief Business 1,143
Development were sold 39,956.19975
& Corporate and 1,280 N/A Single ordinary
Affairs Officer) PDMR 13.4385 retained) Transaction shares 0.00452%
---------- -------- --------------- ------------- ------------------- -----------------
2,268
(of which
Mark Gladwell 1,070
(President were sold 2,801.44339
Operations and 1,198 N/A Single ordinary
& GBS) PDMR 13.4385 retained) Transaction shares 0.00032%
---------- -------- --------------- ------------- ------------------- -----------------
1,927
(of which
Melissa Guerdan 658 were
(Chief Quality sold and 2,551.42336
& Regulatory 1,269 N/A Single ordinary
Affairs Officer) PDMR 13.4385 retained) Transaction shares 0.00029%
---------- -------- --------------- ------------- ------------------- -----------------
6,143
(of which
2,350
Skip Kiil were sold 3,793.53744
(President and 3,793 N/A Single ordinary
Orthopaedics) PDMR 13.4385 retained) Transaction shares 0.00043%
---------- -------- --------------- ------------- ------------------- -----------------
4,608
(of which 98,541.00000
1,819 ordinary
Elga Lohler were sold shares (including
(Chief HR and 2,789 N/A Single 3,105.00000
Officer) PDMR 13.4385 retained) Transaction in ADS') 0.01114%
---------- -------- --------------- ------------- ------------------- -----------------
4,471
Catheryn (of which 72,700.23565
O'Rourke 1,524 ordinary
(Chief Legal were sold shares (including
& Compliance and 2,947 N/A Single 5,818.25734
Officer) PDMR 13.4385 retained) Transaction in ADS') 0.00822%
---------- -------- --------------- ------------- ------------------- -----------------
4,167
(of which
Vasant Padmanabhan 1,414
(President were sold 55,611.00000
Research and 2,753 N/A Single ordinary
& Development) PDMR 13.4385 retained) Transaction shares 0.00628%
---------- -------- --------------- ------------- ------------------- -----------------
1,699
(of which
Susan Swabey 801 were 47,679.83952
(Company sold and N/A Single ordinary
Secretary) PDMR 13.4385 898 retained) Transaction shares 0.00539%
---------- -------- --------------- ------------- ------------------- -----------------
* including those held by Persons Closely Associated with the
Director/PDMR. All figures in these columns are stated to 5 decimal
places where applicable.
2. SUPPLEMENTARY AWARDS GRANTED UNDER THE SMITH & NEPHEW
GLOBAL SHARE PLAN 2020 FOR THE 2018 PERFORMANCE SHARE PROGRAMME
AWARDS:
The Performance Share Programme is designed to incentivise
senior management for performance delivered over a three-year
period. T he impact of COVID-19 in 2020 has had, and will have, a
significant impact on the Performance Share Programme's ability to
recognise performance delivered in preceding and consequent years.
Reflecting these considerations, the following awards of US$0.20
ordinary shares (the "Shares") in Smith & Nephew plc (the
"Company") were granted under the Smith & Nephew Global Share
Plan 2020 ("Supplementary Awards") on 8 March 2021 to the PDMRs
listed below. No Supplementary Award has been granted to either the
Chief Executive Officer or the Chief Financial Officer. Each
Supplementary Award is linked to a Performance Share Programme
award granted in 2018, 2019 and 2020 so that a minimum vesting of
between 50% and 70% of the original award at target will be
achieved. If the 2019 or, as relevant, 2020 Performance Share
Programme award vests at 70% of target or more, the whole of the
Supplementary Award lapses. The Supplementary Award represents 25%
to 35% of the maximum award available to participants.
i. SUPPLEMENTARY AWARDS GRANTED UNDER THE SMITH & NEPHEW
GLOBAL SHARE PLAN 2020 FOR THE 2018 PERFORMANCE SHARE PROGRAMME
AWARDS:
As announced on 3 February 2021, 47% of the target 2018
Performance Share Programme award vested. Therefore a conditional
share award equivalent to 23% of the original 2018 Performance
Share Programme award has been granted to the PDMRs listed below
and will vest 100% on 16 March 2021. No price is payable either
upon grant or vesting of the awards.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
------------------------------------------
LEI 213800ZTMDN8S67S1H61
------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
Description of the Smith & Nephew plc Ordinary Shares of USD
financial instrument, 0.20 each
type of instrument
------------------------------------------
Identification code ISIN: GB0009223206
------------------------------------------
Nature of the transaction Grant of supplementary conditional share
award on 8 March 2021 under the Smith &
Nephew Global Share Plan 2020 relating
to the 2018 Performance Share Programme
awards.
------------------------------------------
Date of Transaction 2021 - 03 - 08
------------------------------------------
Place of Transaction Grant took place outside a trading venue
------------------------------------------
Name Status Price (GBP) Volume(s)* Aggregated information
(Position)
Bradley Cannon PDMR Nil 3,740 N/A Single Transaction
(President Sports
Medicine & ENT)
------- ------------ ----------- -----------------------
Phil Cowdy PDMR Nil 1,781 N/A Single Transaction
(Chief Business
Development &
Corporate Affairs
Officer)
------- ------------ ----------- -----------------------
Elga Lohler PDMR Nil 2,848 N/A Single Transaction
(Chief HR Officer)
------- ------------ ----------- -----------------------
Catheryn O'Rourke PDMR Nil 2,823 N/A Single Transaction
(Chief Legal
& Compliance
Officer)
------- ------------ ----------- -----------------------
Vasant Padmanabhan PDMR Nil 3,207 N/A Single Transaction
(President Research
& Development)
------- ------------ ----------- -----------------------
Susan Swabey PDMR Nil 1,255 N/A Single Transaction
(Company Secretary)
------- ------------ ----------- -----------------------
Total: - Nil 15,654 -
------- ------------ ----------- -----------------------
* The number of shares under the award was calculated by
granting 23% of the original target number of shares awarded under
the related 2018 Performance Share Programme award. The calculation
of the grant was by reference to a share price of 1,291p per share,
being the Company share price as at 6 March 2018, the Mid-Market
Quote the day before grant. No more than a total of 70% of the
target number of shares originally awarded under the Performance
Share Programme shall vest when combining the vesting of the
Supplementary Award and its linked Performance Share Programme
award.
ii. SUPPLEMENTARY AWARDS GRANTED UNDER THE SMITH & NEPHEW
GLOBAL SHARE PLAN 2020 FOR THE 2019 PERFORMANCE SHARE PROGRAMME
AWARDS:
A conditional share award equivalent to 50% of the 2019
Performance Share Programme award has been granted to the PDMRs
listed below and will vest on 7 March 2022, subject to the limit
which is n o more than a total of 70% of the target number of
shares under the 2019 Performance Share Programme award will vest
when combining the vesting of the Supplementary Award and its
linked Performance Share Programme award . Any part of the
Supplementary Award that would cause this limit to be exceeded will
lapse. No price is payable either upon grant or vesting of the
awards.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
------------------------------------------
LEI 213800ZTMDN8S67S1H61
------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
Description of the Smith & Nephew plc Ordinary Shares of USD
financial instrument, 0.20 each
type of instrument
------------------------------------------
Identification code ISIN: GB0009223206
------------------------------------------
Nature of the transaction Grant of supplementary conditional share
award on 8 March 2021 under the Smith &
Nephew Global Share Plan 2020 relating
to the 2019 Performance Share Programme
awards.
------------------------------------------
Date of Transaction 2021 - 03 - 08
------------------------------------------
Place of Transaction Grant took place outside a trading venue
------------------------------------------
Name Status Price (GBP) Volume(s)* Aggregated
(Position) information
Bradley Cannon ( PDMR Nil 7,696 N/A Single
President Sports Transaction
Medicine & ENT)
------- ------------ ----------- -------------
Phil Cowdy PDMR Nil 5,641 N/A Single
(Chief Business Transaction
Development & Corporate
Affairs Officer)
------- ------------ ----------- -------------
Simon Fraser PDMR Nil 6,791 N/A Single
(President Advanced Transaction
Wound Management)
------- ------------ ----------- -------------
Mark Gladwell (President PDMR Nil 6,581 N/A Single
Operations & GBS) Transaction
------- ------------ ----------- -------------
Melissa Guerdan PDMR Nil 6,291 N/A Single
(Chief Quality & Transaction
Regulatory Affairs
Officer)
------- ------------ ----------- -------------
Skip Kiil PDMR Nil 9,722 N/A Single
(President Orthopaedics) Transaction
------- ------------ ----------- -------------
Elga Lohler PDMR Nil 6,680 N/A Single
(Chief HR Officer) Transaction
------- ------------ ----------- -------------
Catheryn O'Rourke PDMR Nil 6,495 N/A Single
(Chief Legal & Compliance Transaction
Officer)
------- ------------ ----------- -------------
Vasant Padmanabhan PDMR Nil 6,595 N/A Single
(President Research Transaction
& Development)
------- ------------ ----------- -------------
Susan Swabey (Company PDMR Nil 2,446 N/A Single
Secretary) Transaction
------- ------------ ----------- -------------
Total: - Nil 64,938 -
------- ------------ ----------- -------------
* This is the maximum number of shares that may vest under the
award, calculated by granting 50% of the original target number of
shares granted under the related 2019 Performance Share Programme
award. The calculation of the grant was by reference to a share
price of 1,462.5p per share, being the Company share price as at 6
March 2019, the Mid-Market Quote the day before grant. The number
of shares that shall vest will be reduced as necessary to ensure
that no more than a total of 70% of the target number of shares
originally awarded under the Performance Share Programme shall vest
when combining the vesting of the Supplementary Award and its
linked Performance Share Programme award.
iii. SUPPLEMENTARY AWARDS GRANTED UNDER THE SMITH & NEPHEW
GLOBAL SHARE PLAN 2020 FOR THE 2020 PERFORMANCE SHARE PROGRAMME
AWARDS:
A conditional share award equivalent to 50% of the 2020
Performance Share Programme award has been granted and will vest on
9 March 2023 , subject to the limit which is that n o more than a
total of 70% of the target number of shares under the 2020
Performance Share Programme award will vest when combining the
vesting of the Supplementary Award and its linked Performance Share
Programme award . Any part of the Supplementary Award that would
cause this limit to be exceeded will lapse. No price is payable
either upon grant or vesting of the awards.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
------------------------------------------
LEI 213800ZTMDN8S67S1H61
------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
Description of the Smith & Nephew plc Ordinary Shares of USD
financial instrument, 0.20 each
type of instrument
------------------------------------------
Identification code ISIN: GB0009223206
------------------------------------------
Nature of the transaction Grant of supplementary conditional share
award on 8 March 2021 under the Smith &
Nephew Global Share Plan 2020 relating
to the 2020 Performance Share Programme
Awards.
------------------------------------------
Date of Transaction 2021 - 03 - 08
------------------------------------------
Place of Transaction Grant took place outside a trading venue
------------------------------------------
Name Status Price (GBP) Volume(s)* Aggregated information
(Position)
Bradley Cannon PDMR Nil 7,406 N/A Single Transaction
( President Sports
Medicine& ENT)
------- ------------ ----------- -----------------------
Phil Cowdy PDMR Nil 4,965 N/A Single Transaction
(Chief Business
Development & Corporate
Affairs Officer)
------- ------------ ----------- -----------------------
Myra Eskes PDMR Nil 7,348 N/A Single Transaction
(President APAC
Region)
------- ------------ ----------- -----------------------
Simon Fraser (President PDMR Nil 6,407 N/A Single Transaction
Advanced Wound
Management)
------- ------------ ----------- -----------------------
Mark Gladwell (President PDMR Nil 6,620 N/A Single Transaction
Operations & GBS)
------- ------------ ----------- -----------------------
Melissa Guerdan PDMR Nil 6,113 N/A Single Transaction
(Chief Quality
& Regulatory Affairs
Officer)
------- ------------ ----------- -----------------------
Skip Kiil PDMR Nil 9,172 N/A Single Transaction
(President Orthopaedics)
------- ------------ ----------- -----------------------
Elga Lohler PDMR Nil 6,618 N/A Single Transaction
(Chief HR Officer)
------- ------------ ----------- -----------------------
Catheryn O'Rourke PDMR Nil 6,434 N/A Single Transaction
(Chief Legal &
Compliance Officer)
------- ------------ ----------- -----------------------
Vasant Padmanabhan PDMR Nil 6,409 N/A Single Transaction
(President Research
& Development)
------- ------------ ----------- -----------------------
Susan Swabey (Company PDMR Nil 2,206 N/A Single Transaction
Secretary)
------- ------------ ----------- -----------------------
Total: - Nil 69,698 -
------- ------------ ----------- -----------------------
* This is the maximum number of shares that may vest under the
award, calculated by granting 50% of the original target number of
shares granted under the related 2020 Performance Share Programme
award. The calculation of the grant was by reference to a share
price of 1,661.5p per share, being the Company share price as at 20
May 2020, the Mid-Market Quote the day before grant. The number of
shares that shall vest will be reduced as necessary to ensure that
no more than a total of 70% of the target number of shares
originally awarded under the Performance Share Programme shall vest
when combining the vesting of the Supplementary Award and its
linked Performance Share Programme award.
3. AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020
On 9 March 2021 the following awards of US$0.20 ordinary shares
(the "Shares") in Smith & Nephew plc (the "Company") were
granted under the Smith & Nephew Global Share Plan 2020. The
awards have been made in London and are based on the closing Share
price on the London Stock Exchange on 8 March 2021 of GBP13.65.
i. EQUITY INCENTIVE PROGRAMME AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020:
The awards will normally vest in equal annual tranches over
three years following the award date subject to continued
achievement of objectives and employment. In the event that
objectives are not met in any of the three years, the portion of
shares due to vest on the following anniversary will lapse.
Participants will receive an additional number of shares equivalent
to the amount of dividend payable per vested share during the
relevant performance period.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
------------------------------------------
LEI 213800ZTMDN8S67S1H61
------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
Description of the Smith & Nephew plc Ordinary Shares of USD
financial instrument, 0.20 each
type of instrument
------------------------------------------
Identification code ISIN: GB0009223206
------------------------------------------
Nature of the transaction Equity Incentive Programme awards granted
on 9 March 2021 under the Smith & Nephew
Global Share Plan 2020.
------------------------------------------
Date of Transaction 2021 - 03 - 09
------------------------------------------
Place of Transaction Grant took place outside a trading venue
------------------------------------------
Name Status Price (s) Volume(s) Aggregated information
(Position)
Bradley Cannon PDMR GBP13.65 19,632 N/A Single Transaction
( President Sports
Medicine & ENT)
------- ---------- ---------- -----------------------
Peter Coenen PDMR GBP13.65 4,908 N/A Single Transaction
(President EMEA
Region)
------- ---------- ---------- -----------------------
Phil Cowdy PDMR GBP13.65 15,744 N/A Single Transaction
(Chief Business
Development & Corporate
Affairs Officer)
------- ---------- ---------- -----------------------
Myra Eskes PDMR GBP13.65 17,131 N/A Single Transaction
(President APAC
Region)
------- ---------- ---------- -----------------------
Simon Fraser PDMR GBP13.65 14,233 N/A Single Transaction
(President Advanced
Wound Management)
------- ---------- ---------- -----------------------
Mark Gladwell PDMR GBP13.65 19,809 N/A Single Transaction
(President Operations
& GBS)
------- ---------- ---------- -----------------------
Melissa Guerdan PDMR GBP13.65 13,844 N/A Single Transaction
(Chief Quality
& Regulatory Affairs
Officer)
------- ---------- ---------- -----------------------
Skip Kiil PDMR GBP13.65 20,377 N/A Single Transaction
(President Orthopaedics)
------- ---------- ---------- -----------------------
Elga Lohler PDMR GBP13.65 17,543 N/A Single Transaction
(Chief HR Officer)
------- ---------- ---------- -----------------------
Catheryn O'Rourke PDMR GBP13.65 15,516 N/A Single Transaction
(Chief Legal &
Compliance Officer)
------- ---------- ---------- -----------------------
Vasant Padmanabhan PDMR GBP13.65 14,546 N/A Single Transaction
(President Research
& Development)
------- ---------- ---------- -----------------------
Susan Swabey PDMR GBP13.65 6,917 N/A Single Transaction
(Company Secretary)
------- ---------- ---------- -----------------------
ii. CONDITIONAL SHARE AWARDS GRANTED UNDER THE SMITH &
NEPHEW GLOBAL SHARE PLAN 2020:
The awards will normally vest a third on the first anniversary
of grant, a third on the second anniversary of grant and the final
third will vest on the third anniversary of grant subject to
continued achievement of objectives and employment.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
--------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
--------------------------------------------
LEI 213800ZTMDN8S67S1H61
--------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
Description of the Smith & Nephew plc Ordinary Shares of USD
financial instrument, 0.20 each
type of instrument
--------------------------------------------
Identification code ISIN: GB0009223206
--------------------------------------------
Nature of the transaction Conditional share awards granted on 9 March
2021 under the Smith & Nephew Global Share
Plan 2020.
--------------------------------------------
Date of Transaction 2021 - 03 - 09
--------------------------------------------
Place of Transaction Grant took place outside a trading venue
--------------------------------------------
Name Price (s) Volume(s) Aggregated
(Position) Status information
Mark Gladwell PDMR GBP13.65 30,476 N/A Single
(President Operations Transaction
& GBS)
--------- ---------- ---------- -------------
Skip Kiil PDMR GBP13.65 37,049 N/A Single
(President Orthopaedics) Transaction
--------- ---------- ---------- -------------
Susan Swabey
Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFSDVRIAIIL
(END) Dow Jones Newswires
March 09, 2021 12:48 ET (17:48 GMT)
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From Mar 2024 to Apr 2024
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From Apr 2023 to Apr 2024
